Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Estimation of tuberculosis incidence at subnational level using three methods to monitor progress towards ending TB in India, 2015-2020.
Jeyashree K, Thangaraj J, Rade K, Modi B, Selvaraju S, Velusamy S, Akhil S, Vijayageetha M, Sudha Rani D, Sabarinathan R, Manikandanesan S, Elumalai R, Natarajan M, Joseph B, Mahapatra A, Shamim A, Shah A, Bhardwaj A, Purty A, Vadera B, Sridhar A, Chowdhury A, Shafie A, Choudhury A, Dhrubjyoti D, Solanki H, Sirmanwar K, Khaparde K, Parmar M, Dahiya N, Debdutta P, Ahmed Q, Ramachandran R, Prasad R, Shinde R, Baruah R, Chauhan S, Bharaswadkar S, Achanta S, Sharath BN, Balakrishnan S, Chandra S, Khumukcham S, Mandal S, Chalil S, Shah V, Roddawar V, Rao R, Sachdeva K, Murhekar M; Subnational TB claims verification group. Jeyashree K, et al. Among authors: selvaraju s. BMJ Open. 2022 Jul 28;12(7):e060197. doi: 10.1136/bmjopen-2021-060197. BMJ Open. 2022. PMID: 35902192 Free PMC article.
Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.
Swaminathan S, Padmapriyadarsini C, Venkatesan P, Narendran G, Ramesh Kumar S, Iliayas S, Menon PA, Selvaraju S, Pooranagangadevi NP, Bhavani PK, Ponnuraja C, Dilip M, Ramachandran R. Swaminathan S, et al. Among authors: selvaraju s. Clin Infect Dis. 2011 Oct;53(7):716-24. doi: 10.1093/cid/cir447. Clin Infect Dis. 2011. PMID: 21890776 Clinical Trial.
Recurrence of tuberculosis among newly diagnosed sputum positive pulmonary tuberculosis patients treated under the Revised National Tuberculosis Control Programme, India: A multi-centric prospective study.
Velayutham B, Chadha VK, Singla N, Narang P, Gangadhar Rao V, Nair S, Ramalingam S, Narayanan Sivaramakrishnan G, Joseph B, Selvaraju S, Shanmugam S, Narang R, Pachikkaran P, Bhat J, Ponnuraja C, Bajaj Bhalla B, Shivashankara BA, Sebastian G, Yadav R, Kumar Sharma R, Sarin R, Myneedu VP, Singla R, Khayyam K, Mrithunjayan SK, Jayasankar SP, Sanker P, Viswanathan K, Viswambharan R, Mathuria K, Bhalla M, Singh N, Tumane KB, Dawale A, Tiwari CP, Bansod R, Jayabal L, Murali L, Khaparde SD, Rao R, Jawahar MS, Natrajan M. Velayutham B, et al. Among authors: selvaraju s. PLoS One. 2018 Jul 6;13(7):e0200150. doi: 10.1371/journal.pone.0200150. eCollection 2018. PLoS One. 2018. PMID: 29979738 Free PMC article.
Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India.
Moonan PK, Nair SA, Agarwal R, Chadha VK, Dewan PK, Gupta UD, Ho CS, Holtz TH, Kumar AM, Kumar N, Kumar P, Maloney SA, Mase SR, Oeltmann JE, Paramasivan CN, Parmar MM, Rade KK, Ramachandran R, Rao R, Salhorta VS, Sarin R, Sarin S, Sachdeva KS, Selvaraju S, Singla R, Surie D, Tonsing J, Tripathy SP, Khaparde SD. Moonan PK, et al. Among authors: selvaraju s. BMJ Glob Health. 2018 Oct 8;3(5):e001135. doi: 10.1136/bmjgh-2018-001135. eCollection 2018. BMJ Glob Health. 2018. PMID: 30364389 Free PMC article.
Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020.
Murhekar MV, Bhatnagar T, Selvaraju S, Rade K, Saravanakumar V, Vivian Thangaraj JW, Kumar MS, Shah N, Sabarinathan R, Turuk A, Anand PK, Asthana S, Balachandar R, Bangar SD, Bansal AK, Bhat J, Chakraborty D, Rangaraju C, Chopra V, Das D, Deb AK, Devi KR, Dwivedi GR, Salim Khan SM, Haq I, Kumar MS, Laxmaiah A, Madhuka, Mahapatra A, Mitra A, Nirmala AR, Pagdhune A, Qurieshi MA, Ramarao T, Sahay S, Sharma YK, Shrinivasa MB, Shukla VK, Singh PK, Viramgami A, Wilson VC, Yadav R, Girish Kumar CP, Luke HE, Ranganathan UD, Babu S, Sekar K, Yadav PD, Sapkal GN, Das A, Das P, Dutta S, Hemalatha R, Kumar A, Narain K, Narasimhaiah S, Panda S, Pati S, Patil S, Sarkar K, Singh S, Kant R, Tripathy S, Toteja GS, Babu GR, Kant S, Muliyil JP, Pandey RM, Sarkar S, Singh SK, Zodpey S, Gangakhedkar RR, S Reddy DC, Bhargava B. Murhekar MV, et al. Among authors: s reddy dc, selvaraju s. Indian J Med Res. 2020 Jul & Aug;152(1 & 2):48-60. doi: 10.4103/ijmr.IJMR_3290_20. Indian J Med Res. 2020. PMID: 32952144 Free PMC article.
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Murhekar MV, Bhatnagar T, Selvaraju S, Saravanakumar V, Thangaraj JWV, Shah N, Kumar MS, Rade K, Sabarinathan R, Asthana S, Balachandar R, Bangar SD, Bansal AK, Bhat J, Chopra V, Das D, Deb AK, Devi KR, Dwivedi GR, Khan SMS, Kumar CPG, Kumar MS, Laxmaiah A, Madhukar M, Mahapatra A, Mohanty SS, Rangaraju C, Turuk A, Baradwaj DK, Chahal AS, Debnath F, Haq I, Kalliath A, Kanungo S, Kshatri JS, Lakshmi GGJN, Mitra A, Nirmala AR, Prasad GV, Qurieshi MA, Sahay S, Sangwan RK, Sekar K, Shukla VK, Singh PK, Singh P, Singh R, Varma DS, Viramgami A, Panda S, Reddy DCS, Bhargava B; ICMR Serosurveillance Group. Murhekar MV, et al. Among authors: selvaraju s. Lancet Glob Health. 2021 Mar;9(3):e257-e266. doi: 10.1016/S2214-109X(20)30544-1. Epub 2021 Jan 27. Lancet Glob Health. 2021. PMID: 33515512 Free PMC article.
149 results